Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome

Wolf, W.M., Wattick, R.A., Kinkade, O.N., and Olfert, M.D. (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity. Int. J. Environ. Res. Public Health, 15.

Bozdag, 2016, The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis, Hum. Reprod., 31, 2841, 10.1093/humrep/dew218

Anagnostis, 2018, Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences, Metabolism, 86, 33, 10.1016/j.metabol.2017.09.016

Dunaif, A., Givens, J.R., Haseltine, F.P., and Merriam, G.R. (1992). Diagnostic criteria for polycystic ovary syndrome. Polycystic Ovary Syndrome, Blackwell Science.

Carmina, 2004, Diagnosis of polycystic ovary syndrome: From NIH criteria to ESHRE-ASRM guidelines, Minerva Ginecol., 56, 1

Azziz, 2009, The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report, Fertil. Steril., 91, 456, 10.1016/j.fertnstert.2008.06.035

Johnson, T., Kaplan, L., Ouyang, P., Rizza, R., and Health, N.I.O. (2012). Evidence-Based Methodology Workshop on Polycystic Ovary Syndrome.

Teede, 2018, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Hum. Reprod., 33, 1602, 10.1093/humrep/dey256

Foroozanfard, 2020, Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: A prospective cohort study, Gynecol. Endocrinol., 36, 61, 10.1080/09513590.2019.1631278

Khan, 2019, Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives, Appl. Clin. Genet., 12, 249, 10.2147/TACG.S200341

Wijs, 2017, Risk factors for stillbirth in a socio-economically disadvantaged urban Australian population, J. Matern-Fetal Neonatal Med., 30, 17, 10.1080/14767058.2016.1265933

Bednarska, 2017, The pathogenesis and treatment of polycystic ovary syndrome: What's new?, Adv. Clin. Exp. Med., 26, 359, 10.17219/acem/59380

Teede, H., Deeks, A., and Moran, L. (2010). Polycystic ovary syndrome: A complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med., 8.

Gilbert, 2018, Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews, Clin. Endocrinol., 89, 683, 10.1111/cen.13828

Palomba, 2015, Pregnancy complications in women with polycystic ovary syndrome, Hum. Reprod. Update, 21, 575, 10.1093/humupd/dmv029

Toulis, 2009, Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: A systematic review and a meta-analysis, Fertil Steril., 92, 667, 10.1016/j.fertnstert.2008.06.045

Ashrafi, 2017, Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome, Oman Med. J., 32, 214, 10.5001/omj.2017.40

Rosenfield, 2015, The Diagnosis of Polycystic Ovary Syndrome in Adolescents, Pediatrics, 136, 1154, 10.1542/peds.2015-1430

Sawyer, 2012, Adolescence: A foundation for future health, Lancet, 379, 1630, 10.1016/S0140-6736(12)60072-5

Indran, 2018, Simplified 4-item criteria for polycystic ovary syndrome: A bridge too far?, Clin. Endocrinol., 89, 202, 10.1111/cen.13755

Milczarek, 2019, Difficulties in diagnostics of polycystic ovary syndrome in adolescents - a preliminary study, Pediatr. Endocrinol. Diabetes Metab., 25, 122, 10.5114/pedm.2019.87177

Li, 2017, Metabolic effect of obesity on polycystic ovary syndrome in adolescents: A meta-analysis, J. Obstet. Gynaecol., 37, 1036, 10.1080/01443615.2017.1318840

Chen, 2006, Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS, Hum. Reprod., 21, 2266, 10.1093/humrep/del175

West, 2014, Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study, Hum. Reprod., 29, 2339, 10.1093/humrep/deu200

Hammond, 1996, Sex hormone-binding globulin: Gene organization and structure/function analyses, Horm. Res., 45, 197, 10.1159/000184787

Lee, 1987, Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens, J. Clin. Endocrinol. Metab., 64, 825, 10.1210/jcem-64-4-825

Hammond, 2011, Diverse roles for sex hormone-binding globulin in reproduction, Biol. Reprod., 85, 431, 10.1095/biolreprod.111.092593

Dunn, 1981, Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma, J. Clin. Endocrinol. Metab., 53, 58, 10.1210/jcem-53-1-58

Karakas, 2017, New biomarkers for diagnosis and management of polycystic ovary syndrome, Clin. Chim. Acta, 471, 248, 10.1016/j.cca.2017.06.009

Elmlinger, 2005, Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age, Clin. Lab., 51, 625

Oya, 2010, Sex hormone-binding globulin and lipid profile in pubertal children, Metabolism, 59, 166, 10.1016/j.metabol.2009.06.033

Murphy, 1990, Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women, Fertil Steril., 53, 35, 10.1016/S0015-0282(16)53212-9

Rannevik, 1995, A longitudinal study of the perimenopausal transition: Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density, Maturitas, 21, 103, 10.1016/0378-5122(94)00869-9

Selva, 2007, Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene, J. Clin. Investig., 117, 3979

Feng, 2019, Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells, Mol. Biol. Rep., 46, 4953, 10.1007/s11033-019-04946-w

Loukovaara, 1995, Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors, J. Clin. Endocrinol. Metab., 80, 160

Selva, 2009, Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha, J. Mol. Endocrinol., 43, 19, 10.1677/JME-09-0025

Pugeat, 2010, Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome, Mol. Cell Endocrinol., 316, 53, 10.1016/j.mce.2009.09.020

Zhu, 2019, Sex hormone-binding globulin and polycystic ovary syndrome, Clin. Chim. Acta, 499, 142, 10.1016/j.cca.2019.09.010

Xie, 2009, Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs, Mol. Endocrinol., 23, 434, 10.1210/me.2007-0531

Feng, 2018, SHBG expression is correlated with PI3K/AKT pathway activity in a cellular model of human insulin resistance, Gynecol. Endocrinol., 34, 567, 10.1080/09513590.2017.1411474

Villena, 2020, Sex hormone-binding globulin overexpression protects against high fat diet induced obesity in transgenic male mice, J. Nutr. Biochem., 85, 108480, 10.1016/j.jnutbio.2020.108480

Aksglaede, 2009, Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty, Diabetes Care, 32, 909, 10.2337/dc08-1618

Le, 2019, Does sex hormone-binding globulin cause insulin resistance during pubertal growth?, Endocr. Connect., 8, 510, 10.1530/EC-19-0044

Kavanagh, 2013, Liver fat and SHBG affect insulin resistance in midlife women: The Study of Women’s Health Across the Nation (SWAN), Obesity, 21, 1031, 10.1002/oby.20077

Lin, 2015, Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS), Clin. Exp. Obstet. Gynecol., 42, 315, 10.12891/ceog1779.2015

Pasquali, 2000, Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 85, 2767, 10.1210/jcem.85.8.6738

Plymate, 1988, Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin, J. Clin. Endocrinol. Metab., 67, 460, 10.1210/jcem-67-3-460

Pasquali, 1995, Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men, J. Clin. Endocrinol. Metab., 80, 654

Dapas, M., Lin, F.T., Nadkarni, G.N., Sisk, R., Legro, R.S., Urbanek, M., Hayes, M.G., and Dunaif, A. (2020). Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis. PLoS Med., 17.

Petersen, 2018, Mechanisms of Insulin Action and Insulin Resistance, Physiol. Rev., 98, 2133, 10.1152/physrev.00063.2017

Wang, 2015, Transcriptional regulation of hepatic lipogenesis, Nat. Rev. Mol. Cell Biol., 16, 678, 10.1038/nrm4074

Winters, 2014, Sex hormone-binding globulin gene expression and insulin resistance, J. Clin. Endocrinol. Metab., 99, E2780, 10.1210/jc.2014-2640

Hernandez, 2019, Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver, J. Clin. Endocrinol. Metab., 104, 1500, 10.1210/jc.2018-00740

Softic, 2016, Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease, Dig. Dis. Sci., 61, 1282, 10.1007/s10620-016-4054-0

Herman, 2016, The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis, Trends Endocrinol. Metab., 27, 719, 10.1016/j.tem.2016.06.005

Selva, 2009, Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression, Endocrinology, 150, 2183, 10.1210/en.2008-1289

Azziz, 2001, Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial, J. Clin. Endocrinol. Metab., 86, 1626

Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G.A., Beguinot, F., and Miele, C. (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci., 20.

Lecube, 2012, Molecular Mechanism of TNFα-Induced Down-Regulation of SHBG Expression, Mol. Endocrinol., 26, 438, 10.1210/me.2011-1321

Hernandez, 2012, IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways, Mol. Endocrinol., 26, 1917, 10.1210/me.2012-1152

Lecube, 2014, Adiponectin upregulates SHBG production: Molecular mechanisms and potential implications, Endocrinology, 155, 2820, 10.1210/en.2014-1072

Liu, 2017, Lower SHBG level is associated with higher leptin and lower adiponectin levels as well as metabolic syndrome, independent of testosterone, Sci. Rep., 7, 2727, 10.1038/s41598-017-03078-0

Yamazaki, 2018, Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages, Mediators Inflamm., 2018, 3062319, 10.1155/2018/3062319

Alinezhad, 2019, The relationship between components of metabolic syndrome and plasma level of sex hormone-binding globulin, Eur. J. Transl. Myol., 29, 8196, 10.4081/ejtm.2019.8196

Siddiqui, 2018, Serum Sex Hormone Binding Globulin (SHBG) Relation with Different Components of Metabolic Syndrome in Men with Type 2 Diabetes, Horm. Metab. Res., 50, 138, 10.1055/s-0043-123348

Faal, 2019, Sex hormone binding globulin for prediction of gestational diabetes mellitus in pre-conception and pregnancy: A systematic review, Diabetes Res. Clin. Pract., 152, 39, 10.1016/j.diabres.2019.04.028

Joffe, 2006, Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease, Ann. Epidemiol., 16, 105, 10.1016/j.annepidem.2005.07.055

Subramanya, 2019, Association of endogenous sex hormone levels with coronary artery calcium progression among post-menopausal women in the Multi-Ethnic Study of Atherosclerosis (MESA), J. Cardiovasc. Comput. Tomogr., 13, 41, 10.1016/j.jcct.2018.09.010

Huang, 2018, Relationship between dietary carbohydrates intake and circulating sex hormone-binding globulin levels in postmenopausal women, J. Diabetes, 10, 467, 10.1111/1753-0407.12550

Ramachandran, 2019, Sex Hormone Binding Globulin: A Review of its Interactions With Testosterone and Age, and its Impact on Mortality in Men With Type 2 Diabetes, Sex. Med. Rev., 7, 669, 10.1016/j.sxmr.2019.06.006

Gyawali, 2019, Higher Serum Sex Hormone-Binding Globulin Levels Are Associated With Incident Cardiovascular Disease in Men, J. Clin. Endocrinol. Metab., 104, 6301, 10.1210/jc.2019-01317

Papatheodoridi, 2018, Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts, Curr. Pharm. Des., 24, 4574, 10.2174/1381612825666190117102111

Stefan, 2019, Non-alcoholic fatty liver disease: Causes, diagnosis, cardiometabolic consequences, and treatment strategies, Lancet Diabetes Endocrinol., 7, 313, 10.1016/S2213-8587(18)30154-2

Targher, 2016, Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: A novel hepato-ovarian axis?, Endocrine, 51, 211, 10.1007/s12020-015-0640-8

Rocha, 2017, Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Systematic review and meta-analysis, J. Endocrinol. Invest., 40, 1279, 10.1007/s40618-017-0708-9

Hernandez, 2017, Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development, Endocrinology, 158, 545

Selva, 2015, SHBG-C57BL/ksJ-db/db: A New Mouse Model to Study SHBG Expression and Regulation During Obesity Development, Endocrinology, 156, 4571, 10.1210/en.2015-1677

Mueller, 2020, Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease, J. Clin. Endocrinol. Metab., 105, dgaa574, 10.1210/clinem/dgaa574

Lim, 2019, Metabolic syndrome in polycystic ovary syndrome: A systematic review, meta-analysis and meta-regression, Obes. Rev., 20, 339, 10.1111/obr.12762

Moran, 2013, Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome, J. Endocrinol. Invest., 36, 1004

Januszewski, 2019, Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS), Ginekol. Pol., 90, 7, 10.5603/GP.2019.0002

Deswal, 2018, Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis, Syst. Biol. Reprod. Med., 64, 12, 10.1080/19396368.2017.1410591

Rosenfield, 2007, Clinical review: Identifying children at risk for polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 92, 787, 10.1210/jc.2006-2012

Anderson, 2014, Childhood obesity and its impact on the development of adolescent PCOS, Semin. Reprod. Med., 32, 202, 10.1055/s-0034-1371092

Littlejohn, 2007, Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome, J. Pediatr. Endocrinol. Metab., 20, 17315528, 10.1515/JPEM.2007.20.1.41

Christensen, 2013, Prevalence of polycystic ovary syndrome in adolescents, Fertil. Steril., 100, 470, 10.1016/j.fertnstert.2013.04.001

Ates, 2018, Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome, J. Obstet. Gynaecol., 38, 236, 10.1080/01443615.2017.1345875

Paschou, 2020, Nonalcoholic fatty liver disease in women with polycystic ovary syndrome, Endocrine, 67, 1, 10.1007/s12020-019-02085-7

Chen, 2016, Hepatic manifestations of women with polycystic ovary syndrome, Best Pract. Res. Clin. Obstet. Gynaecol., 37, 119, 10.1016/j.bpobgyn.2016.03.003

Kumarendran, B., O’Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W., and Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med., 15.

Cai, 2017, High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance, Int. J. Obes., 41, 1341, 10.1038/ijo.2017.116

Setji, 2006, Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 91, 1741, 10.1210/jc.2005-2774

Macut, 2016, Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome, Hum. Reprod., 31, 1347, 10.1093/humrep/dew076

Franks, 2008, Polycystic ovary syndrome in adolescents, Int. J. Obes., 32, 1035, 10.1038/ijo.2008.61

Chang, 2007, The reproductive phenotype in polycystic ovary syndrome, Nat. Clin. Pract. Endocrinol. Metab., 3, 688, 10.1038/ncpendmet0637

Cho, 2006, The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome, Ann. Clin. Biochem., 43, 217, 10.1258/000456306776865188

Shorakae, 2018, Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS, Clin. Endocrinol., 89, 628, 10.1111/cen.13808

Adams, 2016, Enhanced Inflammatory Transcriptome in the Granulosa Cells of Women With Polycystic Ovarian Syndrome, J. Clin. Endocrinol. Metab., 101, 3459, 10.1210/jc.2015-4275

Spaczynski, 1999, Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells, Biol. Reprod., 61, 993, 10.1095/biolreprod61.4.993

Mohammadi, 2017, The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State, J. Reprod. Infertil., 18, 352

Ortega, 2011, Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cell steroidogenesis, Fertil. Steril., 96, S40, 10.1016/j.fertnstert.2011.07.155

Ong, 2019, Paeoniflorin extract reverses dexamethasone-induced testosterone over-secretion through downregulation of cytochrome P450 17A1 expression in primary murine theca cells, J. Ethnopharmacol., 229, 97, 10.1016/j.jep.2018.09.006

Ong, 2017, Targeting Insulin Resistance to Treat the Underlying Basis of Polycystic Ovary Syndrome with Chinese Herbal Medicine, Am. J. Chin. Med., 45, 405, 10.1142/S0192415X17500252

Qu, 2015, Successful Treatment of Polycystic Ovarian Syndrome, Nonalcoholic Fatty Liver Disease and Infertility with Chinese Herbal Medicine: A Case Report, Endocrinol. Metab. Synd., 4, 1000183, 10.4172/2161-1017.1000183

Costello, 2019, Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Assessment and treatment of infertility, Hum. Reprod. Open, 2019, 1, 10.1093/hropen/hoy021

2017, Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome, Reprod. Biol. Endocrinol., 15, 93, 10.1186/s12958-017-0313-y

Amiri, 2018, Comparing the Effects of Combined Oral Contraceptives Containing Progestins With Low Androgenic and Antiandrogenic Activities on the Hypothalamic-Pituitary-Gonadal Axis in Patients With Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis, JMIR Res. Protoc., 7, e113, 10.2196/resprot.9024